Page 25 - Prezentacja programu PowerPoint
P. 25

EM-MED is a family owned company group which has been on the medical market for more than 30 years. In the early years
       EM-MED’s main function was the distribution of disposables. Later medical devices were added to the product portfolio and
       now EM-MED primarily distributes devices in the fields of non-invasive hemodynamic monitoring, neonatology and
       temperature management. Being the local market leader in many product categories a decision was made to move into the
       production of medical devices where our goal is to develop highest quality products. Our latest development is the TrueCool
       therapeutic hypothermia device which is possibly the most advanced device of its kind on the market.

       TrueCool is a therapeutic hypothermia device which is used to deliberately reduce the core body temperature in patients who
       do not regain consciousness after return of spontaneous circulation following a cardiac arrest, as well as in newborns with
       hypoxic-ischemic encephalopathy. This is done to reduce neurological damages by decreasing the brain's oxygen demand and
       to reduce the production of neurotransmitters like glutamate, as well as reducing free radicals that might damage the brain.
       Therapeutic hypothermia may be one of the most important recent clinical advancements in the science of resuscitation.

       Key features of our device:
       •  Non-invasive surface cooling

       •  Multiple automatic and manual cooling and warming programs

       •  Efficient cooling (most probably the fastest cooling times)
       •  High accuracy (most probably the most accurate device on the market)

       •  Pathogen decontamination module (so far we are the only ones that are able to directly address infection concerns)
       •  and many more features that distinguish us from the competition

        The market: The global therapeutic hypothermia systems market is expected to reach USD 2.78 billion by 2023 from USD 2.46
       billion in 2018, growing at a CAGR of 2.5%. If you are a medical device distributor with experience in the ICU, ER or OR
       get in touch with us to discuss distribution opportunities.





                            John Zandbergen                                         Patrick Oh Han Khong
                                                                                                                                                                    Website Catalog
                            Export manager EMEA                                     Export manager APAC

                            john@em-med.com                                         patrick@em-med.com

                            +31 26 848 7183                                         +65 90171822
   20   21   22   23   24   25   26   27   28   29